Valor202020212022202320242025TTMGastos comerciales, generales y administrativos1.73 B1.95 B2 B2.02 B2.23 B2.22 B2.22 BInvestigación y desarrollo———————Beneficio operativo2.45 B3.26 B1.77 B725.6 M1.09 B1.38 B1.38 BTotal de ingresos no operativos-226.3 M52.6 M-16.5 M44.1 M82.3 M-40 M-40 MGastos por intereses, netos de intereses capitalizados207.4 M212.1 M180.3 M199.6 M208.3 M224.1 M224.1 MIngresos no operativos, una vez deducidos los gastos por intereses-401.6 M-202 M-171.5 M-171 M-186.2 M-209.1 M-209.1 MIngresos/gastos extraordinarios-32.1 M42.5 M-25.3 M15.5 M60.2 M-55 M-55 MBeneficio antes de impuestos2.22 B3.15 B1.59 B567.5 M958.1 M1.09 B9.64 BParticipación en los beneficios2.9 M26.5 M5.4 M-1.4 M-1.4 M-13.3 M-13.3 MImpuestos662.1 M747.1 M302 M188.5 M212.4 M229.8 M229.8 MParticipación minoritaria900 K2.2 M1.5 M1.2 M1.1 M1.2 M1.2 MOtros ingresos/gastos después de impuestos———————Beneficio neto antes de actividades interrumpidas1.56 B2.38 B1.28 B379.2 M746 M876.5 M876.5 MOperaciones suspendidas———38.8 M00—Beneficio neto1.56 B2.38 B1.28 B418 M746 M876.5 M876.5 MAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas1.56 B2.38 B1.28 B418 M746 M876.5 M876.5 MBeneficio básico por acción13.7421.1312.074.88.8910.5410.54Beneficio por acción diluido13.6420.95124.778.8410.4610.46Número medio de acciones ordinarias113.26 M112.56 M106.04 M87.1 M83.9 M83.2 M333.3 MAcciones diluidas114.07 M113.49 M106.62 M87.6 M84.4 M83.8 M335.7 MEBITDA3 B3.95 B2.35 B1.28 B1.71 B2.14 B1.98 BEBIT2.37 B3.21 B1.72 B705.6 M1.07 B1.46 B1.3 BCosto de los ingresos9.03 B10.5 B10.49 B8.8 B9.38 B9.94 B9.94 BOtros costes de producción———————Amortización y depreciación (flujo de caja)624.7 M745.1 M633.9 M577.3 M643.5 M681.1 M681.1 M
Labcorp Holdings Inc
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program.